WHO ICTRP trial
A Bioequivalence Study of Two Formulations of Fixed Dose Combination Tablets of…
TCTR20200605001 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20200605001 |
|---|---|
| Public title | A Bioequivalence Study of Two Formulations of Fixed Dose Combination Tablets of Sitagliptin Phosphate Equivalent to Sitagliptin 50 mg and Metformin Hydrochloride 1000 mg in Healthy Thai Volunteers under Fed Conditions |
| Scientific title | A Bioequivalence Study of Two Formulations of Fixed Dose Combination Tablets of Sitagliptin Phosphate Equivalent to Sitagliptin 50 mg and Metformin Hydrochloride 1000 mg in Healthy Thai Volunteers under Fed Conditions |
| Primary sponsor | Novartis (Thailand) Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | Healthy volunteers Healthy volunteers Bioequivalence Sitagliptin Metiformin Fixed dose combunation tablets Pharmacokinetic study;Healthy volunteers Bioequivalence Sitagliptin Metiformin Fixed dose combunation tablets Pharmacokinetic study |
| Interventions | A single dose of Sitagliptin/Metformin 50/1000-mg Tablets, Test Product,A single dose of Sitagliptin/Metformin 50/1000-mg Tablets, Reference Product;Experimental Drug,Active Comparator Drug;SITAGLIPTIN METFORMIN SANDOZ (50/1000),JanumetTM |
| Registration date | May 6, 2020 |
| Target size | 32 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: